Home › Stocks › Pharma & healthcare stocks › Max Healthcare
Pharma & healthcare stocks Valuation research

Max Healthcare fair value — north India's hospital chain

Max runs some of the highest-earning hospitals in India, mostly around Delhi. It is now roughly doubling its beds — the valuation asks what that expansion is worth.

FairStocks Research
Updated 15 Nov 2026 · 4 min read
| NSE: MAXHEALTH ₹947
On this page ▾
  1. The business
  2. What the market assumes
  3. The ten-year record
  4. How it is valued
  5. What decides the value
  6. What could go wrong
  7. The full valuation
  8. Questions
Max Healthcare (MAXHEALTH) fair value — is it overvalued? Price ₹947, P/E 66.8, P/B 8.58, ROE —. Based on 10 years of reported financials. FairStocks.
Max Healthcare at a glance. Share price, P/E, P/B and the ten-year revenue trend, from filed accounts. Updated 15 Nov 2026.
In 30 seconds

The market expects Max Healthcare to carry on much as it has.

At today’s share price, buyers are assuming Max Healthcare grows about 19% a year, forever. Over the last ten years it actually grew about 22% a year. The two are close, so the share price does not need the business to improve or to stumble. It needs it to keep doing roughly what it already does.

  • How it is valued: Discounted cash flow.
  • What the price assumes: 19% growth, against 22% the model takes from its own record.
  • Ten-year record: Between FY2021 and FY2026, Max Healthcare's revenue went from ₹2,505 crore to ₹8,373 crore — it compounded at about 27% a year over 5 years.
  • Biggest swing factor: Revenue per bed. Main risk: Price caps.
Price
₹947
Market cap
₹0.92L Cr
P/E
66.8
P/B
8.58
See Max Healthcare's fair value and the full DCFEvery step of the Max Healthcare working, the scenarios and the report Free during launch →

01High-end hospitals, mostly in the north

Max Healthcare Institute, led by Abhay Soi after his Radiant Life Care took control in 2020, runs a network of large hospitals concentrated in Delhi-NCR, with others in Mumbai, Punjab, Uttarakhand and elsewhere.

Its hospitals earn some of the highest revenue per bed in India thanks to complex procedures and a strong urban patient base. It is adding thousands of beds through new towers and acquisitions.

02What the market is assuming

Work backwards from today's share price and you can see what buyers are quietly taking for granted. Here is the growth that price implies for Max Healthcare, next to what the model assumes from the company's own record.

Market expects
19%
growth priced into today's price
Model assumes
22%
growth the model assumes

The further apart these two numbers are, the bigger the bet a buyer at today's price is making.

03Max Healthcare's record, in plain numbers

Between FY2021 and FY2026, Max Healthcare's revenue went from ₹2,505 crore to ₹8,373 crore — it compounded at about 27% a year over 5 years. It reported a net loss in FY2021, and closed the period with net profit of ₹1,442 crore. In FY2026 it kept 17.2% of revenue as net profit — against a low of -5.5% in FY2021 and a high of 24.2% in FY2023. The latest year added 19.1% to revenue, well behind its own long-run pace.

Revenue₹0.03L → ₹0.08L Cr
212223242526
Earnings per share₹-1.6 → ₹14.8
212223242526
Return on equity12.1% → 29.5%
22232426

Revenue and earnings per share in ₹, return on equity and leverage as ratios — all from the filed statements.

Revenue and net profit by year (₹ crore)
YearRevenueNet profitMargin
FY20212,505-138-5.5%
FY20223,93160515.4%
FY20234,5631,10424.2%
FY20245,4061,05819.6%
FY20257,0281,07615.3%
FY20268,3731,44217.2%

04How Max Healthcare gets valued — and why

Discounted cash flow

This business is valued on the cash it is expected to generate, discounted back at its cost of capital — with growth taken from its own ten-year record rather than from guidance.

05What decides Max Healthcare's value

Revenue per bed

Complex procedures and pricing drive earnings.

New beds

Expansion doubles capacity over several years.

Occupancy

New hospitals need time to fill up.

Acquisitions

Bought hospitals must be turned round.

06What could go wrong

  • Price caps. Government pricing rules could squeeze margins.
  • Expansion strain. New beds dilute returns until they mature.
  • Concentration. Heavy reliance on Delhi-NCR.

07What the full Max Healthcare valuation shows

Model value per share
₹0,000
Upside
+00%
Call
XXXX

Sign in free to see the complete Max Healthcare valuation

  • ✓Fair value per share — from a ten-year discounted cash flow, every step shown
  • ✓The Workbench — change revenue growth, the discount rate or terminal growth and watch Max Healthcare's value move
  • ✓Bull, base and bear cases — and exactly which assumptions move between them
  • ✓Peer comparison — against Apollo Hospitals and other hospital chains
  • ✓Downloadable report — the full write-up, yours to keep
See Max Healthcare's fair value and the full DCF — free
Free during launch · unlimited valuations · no card required

08Questions people ask about Max Healthcare

Who runs Max Healthcare?

Abhay Soi, whose Radiant Life Care took control in 2020.

Why is Max's revenue per bed so high?

Its hospitals handle complex procedures in wealthy urban markets.

Max Healthcare or Apollo — which is better value?

The two largest listed hospital chains, compared side by side on their own page.

Is Max Healthcare overvalued?

At ₹947 the market is pricing in roughly 19% sustained growth, against the ~22% its own record supports. That is less than it has delivered — on these numbers the market is asking the business for less than its own record, which usually means it doubts the record repeats.

What is the intrinsic value of Max Healthcare?

It is computed from the filed financial statements using the method that fits this business (discounted cash flow), with every assumption shown alongside the result. The per-share figure and the full working are in the report.

How much debt does Max Healthcare carry?

Debt to equity stands at 0.30, against 0.09 at the start of the period — the balance sheet is a core input to the cost of capital used here.

About this research

Written by the FairStocks research team from Max Healthcare's filed accounts and last reviewed 5 Oct 2026; the figures refresh as new results are filed. Every valuation uses the method that fits the business and shows its assumptions — see a fully worked example or the valuation guides. Educational research, not investment advice.

See Max Healthcare's fair value and the full DCFUnlock free